Markus Graefen

81.2k total citations · 8 hit papers
927 papers, 26.6k citations indexed

About

Markus Graefen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Rheumatology. According to data from OpenAlex, Markus Graefen has authored 927 papers receiving a total of 26.6k indexed citations (citations by other indexed papers that have themselves been cited), including 761 papers in Pulmonary and Respiratory Medicine, 217 papers in Surgery and 167 papers in Rheumatology. Recurrent topics in Markus Graefen's work include Prostate Cancer Diagnosis and Treatment (637 papers), Prostate Cancer Treatment and Research (579 papers) and Urologic and reproductive health conditions (151 papers). Markus Graefen is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (637 papers), Prostate Cancer Treatment and Research (579 papers) and Urologic and reproductive health conditions (151 papers). Markus Graefen collaborates with scholars based in Germany, Canada and Italy. Markus Graefen's co-authors include Hartwig Huland, Francesco Montorsi, Pierre I. Karakiewicz, Alexander Haese, Thorsten Schlomm, Felix K.‐H. Chun, Thomas Steuber, Alberto Briganti, Shahrokh F. Shariat and Jochen Walz and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Markus Graefen

885 papers receiving 26.1k citations

Hit Papers

Retropubic, Laparoscopic,... 2009 2026 2014 2020 2009 2012 2011 2011 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Retropubic, Laparoscopic, and Robot-Assisted Radical Prostatectomy: A Systematic Review and Cumulative Analysis of Comparative Studies
    2009 695 citations Markus Graefen, Giorgio Guazzoni et al. profile →
  2. Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy
    2012 523 citations Markus Graefen, Giorgio Guazzoni et al. profile →
  3. Reporting and Grading of Complications After Urologic Surgical Procedures: An ad hoc EAU Guidelines Panel Assessment and Recommendations
    2011 446 citations Markus Graefen et al. profile →
  4. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis
    2011 434 citations Maxine Sun, Shahrokh F. Shariat et al. profile →
  5. Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy
    2012 357 citations Peter R. Carroll, Markus Graefen et al. profile →
  6. Systematic Review and Meta-analysis of Perioperative Outcomes and Complications After Robot-assisted Radical Prostatectomy
    2012 350 citations Markus Graefen, Giorgio Guazzoni et al. profile →
  7. Initial Experience of 68Ga-PSMA PET/CT Imaging in High-risk Prostate Cancer Patients Prior to Radical Prostatectomy
    2015 337 citations Lars Budäus, Sami‐Ramzi Leyh‐Bannurah et al. profile →
  8. Positive Surgical Margins After Radical Prostatectomy: A Systematic Review and Contemporary Update
    2013 305 citations Alberto Briganti, Markus Graefen et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Markus Graefen 20.2k 6.7k 5.7k 3.8k 3.5k 927 26.6k
James A. Eastham 21.8k 1.1× 6.0k 0.9× 6.6k 1.2× 4.3k 1.1× 2.9k 0.8× 538 27.3k
Thomas M. Wheeler 17.2k 0.8× 6.0k 0.9× 6.6k 1.2× 4.6k 1.2× 1.7k 0.5× 403 29.8k
Hendrik Van Poppel 19.0k 0.9× 6.5k 1.0× 3.7k 0.6× 3.3k 0.8× 2.3k 0.7× 567 24.9k
Alberto Briganti 15.5k 0.8× 7.0k 1.0× 4.3k 0.7× 3.8k 1.0× 2.7k 0.8× 1.0k 21.6k
Patrick C. Walsh 29.5k 1.5× 8.0k 1.2× 9.4k 1.6× 3.9k 1.0× 7.0k 2.0× 577 40.5k
Hartwig Huland 11.7k 0.6× 4.2k 0.6× 3.4k 0.6× 2.8k 0.7× 2.0k 0.6× 613 17.5k
Axel Heidenreich 14.0k 0.7× 7.2k 1.1× 4.3k 0.7× 3.6k 0.9× 1.8k 0.5× 716 21.5k
Pierre I. Karakiewicz 14.8k 0.7× 17.0k 2.5× 3.5k 0.6× 5.8k 1.5× 5.9k 1.7× 1.0k 30.7k
Judd W. Moul 14.6k 0.7× 3.9k 0.6× 2.8k 0.5× 3.9k 1.0× 1.0k 0.3× 526 20.5k
Fritz H. Schröder 17.5k 0.9× 4.2k 0.6× 3.4k 0.6× 4.3k 1.1× 1.8k 0.5× 501 22.7k

Countries citing papers authored by Markus Graefen

Since Specialization
Citations

This map shows the geographic impact of Markus Graefen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Graefen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Graefen more than expected).

Fields of papers citing papers by Markus Graefen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Graefen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Graefen. The network helps show where Markus Graefen may publish in the future.

Co-authorship network of co-authors of Markus Graefen

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Graefen. A scholar is included among the top collaborators of Markus Graefen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Graefen. Markus Graefen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Longoni, Mattia, Andrea Marmiroli, Fabian Falkenbach, et al.. (2025). Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes. World Journal of Urology. 43(1). 687–687.
2.
Falkenbach, Fabian, Dirk Beyersdorff, Daniel Köehler, et al.. (2024). Bimodal imaging: Detection rate of clinically significant prostate cancer is higher in MRI lesions visible to transrectal ultrasound. The Prostate. 84(16). 1448–1455.
3.
Incesu, Reha‐Baris, Simone Morra, Andrea Baudo, et al.. (2024). Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment. Journal of the National Comprehensive Cancer Network. 22(6). 390–396. 1 indexed citations
4.
Longoni, Mattia, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.. (2024). Survival after trimodal therapy in octogenarians with organ‐confined urothelial bladder cancer. British Journal of Urology. 135(5). 828–834. 1 indexed citations
5.
Hoeh, Benedikt, Rocco Simone Flammia, Lukas Hohenhorst, et al.. (2023). Regional differences in total hospital costs for radical cystectomy in the United States. Surgical Oncology. 48. 101924–101924. 11 indexed citations
6.
Ambrosini, Francesca, Fabian Falkenbach, Lars Budäus, et al.. (2023). Comparative analysis of robot-assisted and open approach for PSMA-radioguided surgery in recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 51(10). 3079–3088. 4 indexed citations
7.
Antonov, Alexandr S., Jessica Hauschild, Olesya I. Zhuravleva, et al.. (2023). New Bioactive β-Resorcylic Acid Derivatives from the Alga-Derived Fungus Penicillium antarcticum KMM 4685. Marine Drugs. 21(3). 178–178. 9 indexed citations
8.
Tilki, Derya, Ming‐Hui Chen, Jing Wu, et al.. (2023). Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of Death. Journal of Clinical Oncology. 41(13). 2428–2435. 24 indexed citations
9.
Dyshlovoy, Sergey A., Olesya I. Zhuravleva, Jessica Hauschild, et al.. (2023). New Marine Fungal Deoxy-14,15-Dehydroisoaustamide Resensitizes Prostate Cancer Cells to Enzalutamide. Marine Drugs. 21(1). 54–54. 9 indexed citations
10.
11.
Devos, Gaëtan, Gert De Meerleer, Wout Devlies, et al.. (2021). Neoadjuvant treatment with androgen receptor signaling inhibitors prior to radical prostatectomy: a systematic review. World Journal of Urology. 39(9). 3177–3185. 8 indexed citations
12.
Pompe, Raisa S., Felix Preißer, Sami‐Ramzi Leyh‐Bannurah, et al.. (2020). Association of very low PSA with increased metastases and death in patients with biopsy Gleason score 8-10 prostate cancer. European Urology Open Science. 19. e1892–e1892. 1 indexed citations
13.
14.
Preißer, Felix, Alexander Heinze, Raisa S. Pompe, et al.. (2020). Impact of positive surgical margin length and Gleason grade at the margin on oncologic outcomes in patients with non-organ-confined prostate cancer. European Urology Open Science. 19. e1375–e1375. 1 indexed citations
15.
Preißer, Felix, Matthew R. Cooperberg, Juanita Crook, et al.. (2020). Intermediate-risk Prostate Cancer: Stratification and Management. European Urology Oncology. 3(3). 270–280. 59 indexed citations
16.
Pompe, Raisa S., Marco Bandini, Felix Preißer, et al.. (2018). Contemporary approach to predict early biochemical recurrence after radical prostatectomy: update of the Walz nomogram. Prostate Cancer and Prostatic Diseases. 21(3). 386–393. 10 indexed citations
17.
Burdelski, Christoph, Claudia Hube‐Magg, Martina Kluth, et al.. (2015). Cytoplasmic Accumulation of Sequestosome 1 (p62) Is a Predictor of Biochemical Recurrence, Rapid Tumor Cell Proliferation, and Genomic Instability in Prostate Cancer. Clinical Cancer Research. 21(15). 3471–3479. 39 indexed citations
18.
Larcher, Alessandro, Maxine Sun, Jonas Schiffmann, et al.. (2014). Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer. European Journal of Surgical Oncology. 41(3). 353–360. 28 indexed citations
19.
Burkhardt, Lia, Antje Krohn, Sawinee Masser, et al.. (2013). CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer. Cancer Research. 73(9). 2795–2805. 130 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James A. Eastham Breakdown of academic impact, for papers by Thomas M. Wheeler Breakdown of academic impact, for papers by Hendrik Van Poppel Breakdown of academic impact, for papers by Alberto Briganti Breakdown of academic impact, for papers by Patrick C. Walsh Breakdown of academic impact, for papers by Hartwig Huland Breakdown of academic impact, for papers by Axel Heidenreich Breakdown of academic impact, for papers by Pierre I. Karakiewicz Breakdown of academic impact, for papers by Judd W. Moul Breakdown of academic impact, for papers by Fritz H. Schröder
Rankless by CCL
2026